Diabetes
Commentary
‘Ozempic face’: Accepting wrinkles for improved health
Some who are taking Ozempic are complaining about their faces thinning as an effect of this weight-loss drug. Dr. Anne Peters thinks the benefit...
From the Journals
Longer diabetes duration links with increased heart failure
Prospective data from nearly 24,000 people with diabetes showed that longer diabetes duration significantly linked with an increased heart failure...
Latest News
Eating potatoes is healthy, study finds
Potatoes are filled with key nutrients,packed with health benefits.
Feature
Exercise halves T2D risk in adults with obesity
Adults with obesity in a supervised exercise program were significantly less likely than nonexercisers to develop type 2 diabetes 10 years later...
Commentary
Managing respiratory symptoms in the ‘tripledemic’ era
Is it COVID-19, flu, or even RSV?
From the Journals
Healthy habits lower T2D microvascular risks: Cohort study
A cohort study confirmed that adopting healthy habits before or after a diabetes diagnosis significantly lowered microvascular complication risks...
From the Journals
More type 2 diabetes deaths from cancer than heart disease
In people with type 2 diabetes, cancer screening should get at least as much attention as CVD prevention.
News
FDA okays Tidepool Loop app to help guide insulin delivery
Prescription-only device works with compatible continuous glucose monitors and insulin pumps for people with type 1 diabetes aged 6 years or older...
From the Journals
EMR screening in emergency department tags undiagnosed diabetes
Missed diabetes diagnoses identified by the EMR screening were especially common in racial and ethnic minorities.
From the Journals
High-deductible health plans detrimental for those with diabetes
Individuals forced to switch to high-deductible plans appear to ration care, leading to more hypo- and hyperglycemic events.
News
FDA approves new type 2 diabetes drug bexagliflozin
Another SGLT2 inhibitor has been approved for type 2 diabetes based on results from 23 clinical trials in 5,000 patients.